MANE (MANE)
95.70
+2.72 (2.93%)
Upcoming Events
Latest Headlines
Achieve Life Sciences adds two board members ahead of drug resubmission
June 2, 2026 8:31 AM - StreetInsider
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
June 2, 2026 8:30 AM - Globe NewsWire
Needham Starts Veradermics (MANE) at Buy
June 2, 2026 5:33 AM - StreetInsider
Veradermics to Present at Upcoming June Investor Conferences
May 28, 2026 4:30 PM - BizWire
Veradermics to present hair loss drug trial results at research congress
May 27, 2026 7:30 AM - StreetInsider
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
May 27, 2026 7:30 AM - BizWire
Form SCHEDULE 13G/A Veradermics, Inc Filed by: VIKING GLOBAL INVESTORS LP
May 15, 2026 5:52 PM - SEC Filing
Form D Veradermics, Inc
May 15, 2026 2:02 PM - SEC Filing
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
May 14, 2026 7:30 AM - BizWire
Form 10-Q Veradermics, Inc For: Mar 31
May 12, 2026 5:07 PM - SEC Filing
Form 8-K Veradermics, Inc For: May 12
May 12, 2026 8:33 AM - SEC Filing
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
May 12, 2026 7:30 AM - BizWire
Form SCHEDULE 13G Veradermics, Inc Filed by: CITADEL ADVISORS LLC
May 7, 2026 4:42 PM - SEC Filing
Form SCHEDULE 13D/A Veradermics, Inc Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
May 5, 2026 9:39 PM - SEC Filing
Form 4 Veradermics, Inc For: May 01 Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
May 5, 2026 9:38 PM - SEC Filing
Form SCHEDULE 13D/A Veradermics, Inc Filed by: Longitude Capital Partners V, LLC
May 5, 2026 9:08 PM - SEC Filing
Form SCHEDULE 13D Veradermics, Inc Filed by: Seven Fleet Capital Management LP
May 5, 2026 7:44 PM - SEC Filing
Form 3 Veradermics, Inc For: May 01 Filed by: Seven Fleet Capital Management LP
May 5, 2026 7:42 PM - SEC Filing
Form 8-K Veradermics, Inc For: May 01
May 1, 2026 4:35 PM - SEC Filing
Form 424B4 Veradermics, Inc
April 30, 2026 5:30 PM - SEC Filing
Veradermics (MANE) PT Raised to $138 at Jefferies
April 30, 2026 1:39 PM - StreetInsider
Form EFFECT Veradermics, Inc
April 30, 2026 6:16 AM - SEC Filing
Form FWP Veradermics, Inc Filed by: Veradermics, Inc
April 30, 2026 6:15 AM - SEC Filing
Veradermics prices $384.4 million public offering at $100 per share
April 29, 2026 10:32 PM - StreetInsider
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
April 29, 2026 10:32 PM - BizWire
Form S-1MEF Veradermics, Inc
April 29, 2026 9:45 PM - SEC Filing
Form FWP Veradermics, Inc Filed by: Veradermics, Inc
April 27, 2026 5:28 PM - SEC Filing
Veradermics launches public offering of 3.35 million shares
April 27, 2026 5:26 PM - StreetInsider
Veradermics Announces Launch of Public Offering
April 27, 2026 5:26 PM - BizWire
Form S-1 Veradermics, Inc
April 27, 2026 5:18 PM - SEC Filing
Form 8-K Veradermics, Inc For: Apr 27
April 27, 2026 5:18 PM - SEC Filing
Veradermics (MANE) PT Raised to $120 at Citi
April 27, 2026 2:32 PM - StreetInsider
Form 8-K Veradermics, Inc For: Apr 27
April 27, 2026 9:11 AM - SEC Filing
Veradermics reports positive Phase 2/3 trial results for hair loss drug
April 27, 2026 7:00 AM - StreetInsider
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
April 27, 2026 7:00 AM - BizWire
Veradermics schedules conference call for hair loss drug trial results
April 26, 2026 4:00 PM - StreetInsider
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
April 26, 2026 4:00 PM - BizWire
Veradermics (MANE) PT Raised to $111 at Jefferies
April 22, 2026 6:07 AM - StreetInsider
Form 10-K Veradermics, Inc For: Dec 31
March 30, 2026 5:47 PM - SEC Filing
Form 8-K Veradermics, Inc For: Mar 30
March 30, 2026 8:45 AM - SEC Filing
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
March 30, 2026 7:30 AM - BizWire
Jefferies: 'We hosted an oversubscribed investor dinner with MANE'
March 26, 2026 10:07 AM - StreetInsider
Veradermics to present hair loss drug data at dermatology meeting
March 18, 2026 7:00 AM - StreetInsider
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
March 18, 2026 7:00 AM - BizWire
Full Article List
